JP2003252899A - Epitope having immunologic reactivity for farm animal serum albumin - Google Patents

Epitope having immunologic reactivity for farm animal serum albumin

Info

Publication number
JP2003252899A
JP2003252899A JP2002057150A JP2002057150A JP2003252899A JP 2003252899 A JP2003252899 A JP 2003252899A JP 2002057150 A JP2002057150 A JP 2002057150A JP 2002057150 A JP2002057150 A JP 2002057150A JP 2003252899 A JP2003252899 A JP 2003252899A
Authority
JP
Japan
Prior art keywords
lys
val
leu
serum albumin
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002057150A
Other languages
Japanese (ja)
Inventor
Souichi Tanabe
創一 田辺
Toshihide Nishimura
敏英 西村
Yoshihisa Takahata
能久 高畑
Fumitake Morimatsu
文毅 森松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NH Foods Ltd
Original Assignee
Nippon Meat Packers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Meat Packers Inc filed Critical Nippon Meat Packers Inc
Priority to JP2002057150A priority Critical patent/JP2003252899A/en
Publication of JP2003252899A publication Critical patent/JP2003252899A/en
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an epitope (peptide) of bovine serum albumin or sheep serum albumin, having immunologic reactivity for the human or a pet animal, and to provide a method for determining an epitope having immunologic reactivity of farm animal serum albumin. <P>SOLUTION: The method for determining an epitope having immunologic reactivity comprises comparing the amino acid sequence of human serum albumin with a farm animal serum albumin, preparing the peptide corresponding to a different part thereof, referring the obtained to an immunological test and finding out a peptide having immunologic reactivity. And an epitope having immunologic reactivity, of bovine serum albumin or sheep serum albumin, and determined by the method is provided. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明はウシ血清アルブミン
(以下、BSAという)又はヒツジ血清アルブミン(以
下、SSAという)のヒト又はペット動物に対する免疫
学的反応性を有するエピトープ(ペプチド)及び家畜血
清アルブミンの免疫学的反応性を有するエピトープの決
定方法に関する。
TECHNICAL FIELD [0001] The present invention relates to an epitope (peptide) of bovine serum albumin (hereinafter referred to as BSA) or sheep serum albumin (hereinafter referred to as SSA) having immunological reactivity to humans or pet animals, and livestock serum albumin. And a method for determining an epitope having immunological reactivity.

【0002】[0002]

【従来の技術】近年、食物アレルギー患者が増加してお
り、所謂、5大アレルゲン(牛乳、卵、小麦、そば、落
花生)が知られている。また、5大アレルゲンほどメジ
ャーなアレルゲンではないが、食肉もアレルギーを起こ
す場合がある。例えば、牛肉はアレルゲン性を示す。そ
して、牛肉アレルギーの研究から、牛肉の主要なアレル
ゲンはBSAであることが知られている。BSAは牛乳
にも含まれているので、牛肉アレルギー患者は牛乳を摂
取した場合にもアレルギーを発症する。同様に、牛乳ア
レルギー患者は牛肉を摂取した場合にもアレルギーを発
症する。また、犬、猫などのペット動物は牛肉でアレル
ギーを生じることが知られている。アレルゲンを検査す
る方法の一つとして、患者血清中のIgE抗体を利用す
る免疫学的検査法がある。しかし、患者血清を大量に入
手するのは難しいから、この方法の実施には限界があ
る。そこで、汎用的に実施可能な免疫学的検査法が必要
とされている。また、免疫学的検査法に供する抗体とし
てはアレルゲンを特異的に認識する抗体が望ましく、ア
レルギーを惹起する物質、その構成成分(多くの場合、
蛋白質)又はそのアミノ酸配列(免疫学的反応性を有す
るエピトープ)を特定し、それを抗原として作製された
抗体が望ましい。免疫学的反応性エピトープを特定する
方法としては、1)アレルゲンを酵素処理又は化学的処
理により調製した限定分解物と患者IgE抗体の反応性
を調べる方法、2)アミノ酸配列データベースを参照し
て合成したオーバーラップペプチドと患者IgE抗体の
反応性を調べる方法などが知られているが、非常に手間
のかかる効率の悪い方法であった。一方、上述のよう
に、牛肉の主要なアレルゲンはBSAであることが知ら
れていたが、BSA中の免疫学的反応性を有するエピト
ープについては知られていなかった。また、アレルゲン
性を示す蛋白質のアミノ酸配列中には、T細胞のレセプ
ターと結合し、T細胞に免疫学的刺激を与えるエピトー
プの存在が言われているが、このBSAでの検討はなさ
れていなかった。
2. Description of the Related Art In recent years, the number of patients with food allergy has been increasing, and so-called five major allergens (milk, eggs, wheat, buckwheat, peanuts) are known. Although not as major as the five major allergens, meat may also cause allergies. For example, beef is allergenic. And it is known from the study of beef allergy that BSA is the main allergen of beef. Since BSA is also contained in milk, beef allergic patients also develop allergies when ingesting milk. Similarly, milk allergic patients also develop allergies when ingesting beef. It is known that pet animals such as dogs and cats are allergic to beef. As one of the methods for testing allergens, there is an immunological test method using IgE antibody in patient serum. However, it is difficult to obtain a large amount of patient serum, and thus there are limits to the implementation of this method. Therefore, there is a need for an immunological test method that can be performed universally. In addition, an antibody that specifically recognizes an allergen is desirable as an antibody to be subjected to an immunological test method, and a substance that causes an allergy, its constituent components (often,
A protein) or its amino acid sequence (epitope having immunological reactivity) is specified, and an antibody produced using it as an antigen is desirable. As a method for identifying an immunologically reactive epitope, 1) a method for investigating the reactivity of a limited degradation product prepared by enzymatic or chemical treatment of an allergen with a patient IgE antibody, 2) synthesis with reference to an amino acid sequence database Although a method for examining the reactivity of the overlapping peptide with the IgE antibody of the patient is known, it is a very laborious and inefficient method. On the other hand, as described above, the major allergen of beef was known to be BSA, but the immunologically reactive epitope in BSA was not known. In addition, it is said that there is an epitope in the amino acid sequence of the protein exhibiting allergenicity, which binds to the receptor of T cell and gives immunological stimulation to T cell, but this BSA has not examined it. It was

【0003】[0003]

【発明が解決しようとする課題】上述のように、従来の
エピトープ決定方法はかなりの時間を必要とするもので
あった。係る問題から、発明者らは、家畜血清アルブミ
ンの免疫学的反応性を有するエピトープ構造の新規な決
定方法を検討した結果、ヒト血清アルブミンと家畜血清
アルブミンのアミノ酸配列を比較し、アミノ酸配列の異
なる個所のペプチドを調製し、それらを免疫学的検査に
付して、免疫学的反応性を有するペプチドを見出すこと
により免疫学的反応性を有するエピトープを容易に決定
することができることを見出した。本発明は、係る方法
により決定されたBSA及びSSAの免疫学的反応性を
有するエピトープ並びに免疫学的反応性を有するエピト
ープの決定方法を提供するものである。なお、ここで免
疫学的反応性とは、IgE抗体(言い換えればB細胞)
及び/又はT細胞のレセプターとの反応性のことであ
る。
SUMMARY OF THE INVENTION As described above, the conventional epitope determination method requires a considerable amount of time. Based on such a problem, the inventors have investigated a novel method for determining the epitope structure of livestock serum albumin having immunological reactivity, and as a result, compared the amino acid sequences of human serum albumin and livestock serum albumin, and found that the amino acid sequences differed. It was found that the epitope having immunological reactivity can be easily determined by preparing peptides at a certain position and subjecting them to an immunological test to find peptides having immunological reactivity. The present invention provides an immunologically reactive epitope of BSA and SSA determined by such a method, and a method of determining an immunologically reactive epitope. The immunological reactivity here means IgE antibody (in other words, B cell).
And / or T cell reactivity with the receptor.

【0004】[0004]

【課題を解決するための手段】上記の課題を解決すべく
なされた本発明は、 (1)下記のアミノ酸配列又はそのN末端及び/又はC末
端に1〜5個のアミノ酸が付加したアミノ酸配列を有す
るBSAの免疫学的反応性を有するエピトープ; Ser-Pro-Asp-Leu-Pro-Lys-Leu-Lys-Pro-Asp-Pro-Asn-Th
r-Leu- Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Ala-Cys-Tyr-Thr-Ser-Val-Phe-Asp-Lys-Leu-Lys-His-Le
u-Val-Asp- Leu-Ile-Leu-Asn-Arg- Glu-Ser-Lys- Ala-Phe-Asp-Glu-Lys-Leu- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe-Val- (2)下記のアミノ酸配列又はそのN末端及び/又はC末
端に1〜5個のアミノ酸が付加したアミノ酸配列を有す
るSSAの免疫学的反応性を有するエピトープ; Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Leu-Ile-Leu-Asn-Arg- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe-Val- (3)家畜の血清アルブミンのアミノ酸配列と、ヒト又は
ペット動物の血清アルブミンのアミノ酸配列を対比し、
アミノ酸配列の異なる個所のアミノ酸配列のペプチドを
免疫学的検査に付して免疫学的反応性を試験し、免疫学
的反応性を有するペプチドを免疫学的反応性を有するエ
ピトープと決定する家畜血清アルブミンの免疫学的反応
性を有するエピトープの決定方法;である。
Means for Solving the Problems The present invention, which has been made to solve the above problems, provides (1) the following amino acid sequence or an amino acid sequence in which 1 to 5 amino acids are added to its N-terminal and / or C-terminal Having an immunological reactivity with BSA having: Ser-Pro-Asp-Leu-Pro-Lys-Leu-Lys-Pro-Asp-Pro-Asn-Th
r-Leu- Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Ala-Cys-Tyr-Thr-Ser-Val-Phe- Asp-Lys-Leu-Lys-His-Le
u-Val-Asp- Leu-Ile-Leu-Asn-Arg- Glu-Ser-Lys- Ala-Phe-Asp-Glu-Lys-Leu- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe- Val- (2) An immunologically reactive epitope of SSA having the following amino acid sequence or an amino acid sequence in which 1 to 5 amino acids are added to its N-terminal and / or C-terminal; Tyr-Ala-Asn-Lys -Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Leu-Ile-Leu-Asn-Arg- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe -Val- (3) Compare the amino acid sequence of livestock serum albumin with the amino acid sequence of human or pet animal serum albumin,
Animal sera in which peptides having amino acid sequences having different amino acid sequences are subjected to immunological tests to test immunological reactivity and peptides having immunological reactivity are determined as epitopes having immunological reactivity And a method for determining an immunologically reactive epitope of albumin.

【0005】[0005]

【発明の実施の形態】前述のように、牛肉の主要アレル
ゲンはBSAであることが知られている。Fiocchi等は
皮膚のプリックテストで牛肉アレルギーの子供たち全員
がBSAに反応することを報告している。しかしなが
ら、今まで、その免疫学的反応性を有するエピトープに
関する実際に役立つ情報はほとんど無かった。血清アル
ブミンは生化学的には最も広く研究され活用されている
蛋白質の一つである。血清蛋白質中、約60%を占め
る。BSAとヒト血清アルブミン(以下、HSAとい
う)のホモロジーは約76%であり、ジスルフィド結合
の繰り返しパターンを厳密に保存している。血清の主要
な構成物質がアレルゲンとして働くと言うことは驚くべ
きことである。
BEST MODE FOR CARRYING OUT THE INVENTION As described above, it is known that the major allergen of beef is BSA. In a skin prick test, Fiocchi et al. Report that all children with beef allergy respond to BSA. However, to date there has been little practical information about the immunologically reactive epitopes. Serum albumin is one of the most widely studied and utilized proteins biochemically. It accounts for about 60% of serum proteins. The homology between BSA and human serum albumin (hereinafter referred to as HSA) is about 76%, and the repeating pattern of disulfide bonds is strictly preserved. It is surprising that the major constituents of serum act as allergens.

【0006】そこで、BSAに対する牛肉アレルギー患
者の免疫学的反応性を検討した。予備実験からBSAに
感受性の牛肉アレルゲンの患者のIgE抗体はHSAと結
合しないことが分かった。そこで、BSAとHSAのア
ミノ酸配列を詳細に比較したところ、アミノ酸配列の非
常に異なる15のエピトープが見出された。そこで、こ
れらのペプチドを合成し、食肉アレルギー患者のIgE
抗体(言い換えれば、B細胞)との反応性及び末梢血単
核球分画(言い換えれば、T細胞)との反応性を調べ
た。
Therefore, the immunological reactivity of beef allergy patients to BSA was examined. Preliminary experiments have shown that IgE antibodies of patients with beef allergens sensitive to BSA do not bind HSA. Therefore, when the amino acid sequences of BSA and HSA were compared in detail, 15 epitopes having very different amino acid sequences were found. Therefore, these peptides were synthesized to produce IgE in patients with meat allergy.
The reactivity with the antibody (in other words, B cell) and the reactivity with the peripheral blood mononuclear cell fraction (in other words, T cell) were examined.

【0007】その結果、下記のアミノ酸配列又はそのN
末端及び/又はC末端に1〜5個のアミノ酸、好ましく
は相同性アミノ酸を付加したアミノ酸配列を有するペプ
チドがBSA分子中の免疫学的反応性を有するエピトー
プとして同定された。なお、上記の相同性アミノ酸と
は、BSAのアミノ酸配列番号のうち、1)下記のアミ
ノ酸配列のN末端及び/又はC末端に位置する配列番号
のアミノ酸であって、且つ2)BSAとHSAのアミノ
酸配列に共通するアミノ酸をいう(SSAにおいても同
様)。ここで、両末端に付加された1〜5個のアミノ酸
はプレートに繋ぐスペーサーの役目を有するもので、免
疫学的反応性を有する限り、この部分を変更しても結合
性に影響はなかった。 Ser-Pro-Asp-Leu-Pro-Lys-Leu-Lys-Pro-Asp-Pro-Asn-Th
r-Leu- Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Ala-Cys-Tyr-Thr-Ser-Val-Phe-Asp-Lys-Leu-Lys-His-Le
u-Val-Asp- Leu-Ile-Leu-Asn-Arg- Glu-Ser-Lys- Ala-Phe-Asp-Glu-Lys-Leu- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe-Val- これらのペプチドを抗原として調製した抗体は、牛肉ア
レルギー患者が食する食品中のBSAの検定に有用であ
り、牛肉アレルギー患者の食物アレルギーの防止に有用
である。
As a result, the following amino acid sequence or its N
A peptide having an amino acid sequence in which 1 to 5 amino acids, preferably homologous amino acids, were added to the terminal and / or C-terminal was identified as an immunologically reactive epitope in the BSA molecule. The above-mentioned homologous amino acid means, among the amino acid sequence numbers of BSA, 1) an amino acid having the sequence number located at the N-terminal and / or C-terminal of the following amino acid sequence, and 2) between BSA and HSA It refers to the amino acids that are common to the amino acid sequences (same for SSA). Here, the 1 to 5 amino acids added to both ends have a role of a spacer that connects to the plate, and as long as it has immunological reactivity, changing this portion did not affect the binding property. . Ser-Pro-Asp-Leu-Pro-Lys-Leu-Lys-Pro-Asp-Pro-Asn-Th
r-Leu- Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Ala-Cys-Tyr-Thr-Ser-Val-Phe- Asp-Lys-Leu-Lys-His-Le
u-Val-Asp- Leu-Ile-Leu-Asn-Arg- Glu-Ser-Lys- Ala-Phe-Asp-Glu-Lys-Leu- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe- Val-Antibodies prepared using these peptides as antigens are useful for assaying BSA in foods eaten by beef allergy patients, and are useful for preventing food allergy in beef allergy patients.

【0008】また、同様な方法で、SSAについて検討
したところ、下記のアミノ酸配列又はそのN末端及び/
又はC末端に1〜5個のアミノ酸、好ましくは相同性ア
ミノ酸を付加したアミノ酸配列を有するペプチドがSS
A分子中の免疫学的反応性を有するエピトープとして同
定された。 Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Leu-Ile-Leu-Asn-Arg- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe-Val-
When SSA was examined in the same manner, the following amino acid sequence or its N-terminal and / or
Alternatively, a peptide having an amino acid sequence in which 1 to 5 amino acids, preferably homologous amino acids, are added to the C-terminal is
It was identified as an immunologically reactive epitope in the A molecule. Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Leu-Ile-Leu-Asn-Arg- Pro-Asp-Thr-Glu- Lys- Glu-Asn-Phe-Val-

【0009】[0009]

【実施例】以下、実施例に基づいて、本発明をより詳細
に説明するが、本発明はこれらの実施例に限定されるも
のではない。なお、以下に述べられる試験方法及び材料
の概略は下記のとおりである。
The present invention will be described in more detail based on the following examples, but the invention is not intended to be limited to these examples. The test methods and materials described below are summarized below.

【0010】(1)供試血清 インフォームドコンセントを得て採取した牛肉アレルギ
ー患者12名(CAP-RASTスコア:食肉4〜6;牛乳3〜
6)及び健常成人1名の血清を供試した。BSA(Sigma
社製)を常法通りSDS-PAGEし、PVDF膜に転写し、該PVDF
膜と供試患者血清を反応させ、抗ヒトIgE抗体を2次抗
体とするウエスタンブロッティングを行ったところ、供
試患者血清はBSAと反応した。一方、同様に処理した
供試健常成人血清はBSAと反応しなかった。
(1) Twelve beef allergy patients obtained by obtaining test serum informed consent (CAP-RAST score: meat 4 to 6; milk 3 to
6) and one healthy adult were tested. BSA (Sigma
Manufactured by SDS-PAGE in the usual way and transferred to PVDF membrane
When the membrane was reacted with the test patient serum and Western blotting was carried out using an anti-human IgE antibody as a secondary antibody, the test patient serum reacted with BSA. On the other hand, the test healthy adult serum treated in the same manner did not react with BSA.

【0011】(2)ペプチドの合成 NCBI(National Center for Biotechnology Informatio
n)の蛋白質データバンクを参照にして、BSAとHSAのアミ
ノ酸配列を比較した。なお、BSAの配列についてはNC
BIの登録番号229552と登録番号P02769(個々のデータが
不完全なため)、HSAの配列についてはNCBIの登録番
号5821846を元にした。表1に示すように、BSAのアミノ
酸配列に相当するペプチドをペプチドシンセサイザー
(PSSM-8)で合成し、合成したペプチドを逆相HPLCにか
け、主要ピークを集め、凍結乾燥し、DMSO(ジメチルス
ルホキシド)に5mM濃度で溶解し−80℃で保存された。な
お、表1において、便宜上、アミノ酸は常法に準じて1
文字表記で示している(表2も同様)。
(2) Synthesis of peptide NCBI (National Center for Biotechnology Informatio
The amino acid sequences of BSA and HSA were compared with reference to the protein data bank of n). The sequence of BSA is NC
BI accession number 229552 and accession number P02769 (due to incomplete individual data), and HSA sequence based on NCBI accession number 5821846. As shown in Table 1, a peptide corresponding to the amino acid sequence of BSA was synthesized with a peptide synthesizer (PSSM-8), the synthesized peptide was subjected to reverse phase HPLC, the main peaks were collected, freeze-dried, and DMSO (dimethyl sulfoxide). It was dissolved at a concentration of 5 mM in and stored at -80 ° C. In Table 1, for the sake of convenience, amino acids are represented by 1 according to the conventional method.
It is shown in letter notation (same for Table 2).

【0012】[0012]

【表1】 [Table 1]

【0013】また、NCBIの蛋白質データバンクを参照に
して、BSAとSSAのアミノ酸配列を比較した。BSAのデ
ータは2つの配列(登録番号229552とP02769)、SSA
は登録番号113582を元にした。ここで分るように、BS
AとSSAはペプチドNo.4以外は完全に同じエピトープ
を持っていた(表2参照)。また、ペプチドNo.4におい
ても、免疫学的反応性を有するエピトープであるTyr-Al
a-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln-は一致していた。
更に、ここで見出したエピトープは、ウシとヒツジと同
様に反芻動物であるヤギの免疫学的反応性を有するエピ
トープとしても用いることができる。
The amino acid sequences of BSA and SSA were compared with reference to the NCBI protein data bank. The data of BSA are two sequences (registration number 229552 and P02769), SSA
Is based on registration number 113582. As you can see here, BS
A and SSA had completely the same epitope except peptide No. 4 (see Table 2). Also in peptide No. 4, Tyr-Al which is an immunologically reactive epitope
a-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- were in agreement.
Furthermore, the epitopes found here can be used as immunologically reactive epitopes of ruminant goats as well as cattle and sheep.

【0014】[0014]

【表2】 [Table 2]

【0015】また、同様にNCBIの蛋白質データバンクを
参照に、上述のBSAデータとペットである犬や猫の血
清アルブミンのアミノ酸配列データを比較することによ
り、BSAとHSAの場合と同様に、犬や猫に対するB
SAの免疫学的反応性を有するエピトープを見出すこと
ができる。
Similarly, by referring to the protein data bank of NCBI and comparing the above-mentioned BSA data with amino acid sequence data of serum albumin of pet dogs and cats, the same as in the case of BSA and HSA, B for cats and cats
Epitopes with immunological reactivity of SA can be found.

【0016】(3)合成ペプチドに対するIgE抗体の反応性 ペプチド溶液を4倍量の0.1M炭酸バッファー(pH9.6)
で希釈し、その100μlをGregorius等の方法によりプレ
ートのウェルに固定化し、200μl の1%HSAでブロッ
キングした後、患者血清を作用させた。ペプチドに結合
したIgE抗体をビオチン化抗ヒトIgE抗体(Kirkegaard&P
erry Lab.Inc., U.S.A.)とストレプトアビジン-ペルオ
キシダーゼ複合体(Boehringer Mannheim, Germany)と
0-フェニレンジアミン(和光製薬)で検出した。その結
果を図1に示す。結論として、ペプチドは、牛肉アレル
ギー患者IgE抗体(言い換えれば、該患者のB細胞)と
免疫学的反応性を有することが判明した。
(3) Reactive peptide solution of IgE antibody against synthetic peptide 4 times volume of 0.1M carbonate buffer (pH 9.6)
100 μl was fixed to the wells of the plate by the method of Gregorius et al., Blocked with 200 μl of 1% HSA, and then treated with patient serum. The peptide-bound IgE antibody is a biotinylated anti-human IgE antibody (Kirkegaard & P
erry Lab. Inc., USA) and streptavidin-peroxidase complex (Boehringer Mannheim, Germany)
It was detected with 0-phenylenediamine (Wako Pharmaceutical Co., Ltd.). The result is shown in FIG. In conclusion, the peptide was found to have immunological reactivity with the IgE antibody of beef allergy patients (in other words, the B cells of the patient).

【0017】(4)合成ペプチドに対するT細胞の反応性 B細胞によるアレルゲン特異的IgE抗体の産生はアレ
ルゲン特異的T細胞により制御されている。そこで、表
1の合成ペプチドNo.11と牛肉アレルギー患者のT細胞
との反応性を調べた。4名の牛肉アレルギー患者から採
取した血液から常法に従って、末梢単核球分画を調製
し、培養プレート(Nunc社製)に1X10個/ウェルで
播種し、合成ペプチド存在下(50mM)及び非存在下
で培養し、5-ブロモ-2'-デオキシウリジンの取り込み量
を測定し、T細胞の増殖、即ちT細胞との反応性を調べ
た。その結果、該ペプチドは牛肉アレルギー患者のT細
胞と反応することが確認された。
(4) Reactivity of T cells to synthetic peptide Production of allergen-specific IgE antibody by B cells is controlled by allergen-specific T cells. Therefore, the reactivity of the synthetic peptide No. 11 in Table 1 with T cells of beef allergy patients was examined. Peripheral mononuclear cell fractions were prepared from blood collected from 4 beef allergy patients according to a conventional method and seeded on a culture plate (Nunc) at 1 × 10 5 cells / well, in the presence of synthetic peptide (50 mM) and The cells were cultured in the absence, and the uptake of 5-bromo-2'-deoxyuridine was measured to examine the proliferation of T cells, that is, the reactivity with T cells. As a result, it was confirmed that the peptide reacts with T cells of beef allergy patients.

【0018】[0018]

【発明の効果】以上のように、本発明の免疫学的反応性
を有するエピトープは、牛肉アレルギー患者のIgE抗体
(即ち、B細胞)と特異的に反応するので、BSAのア
レルゲン検出用抗体作製のための抗原として活用するこ
とができる。また、本発明の免疫学的反応性を有するエ
ピトープを指標として牛肉及び牛乳並びにこれらを含む
加工食品の低アレルゲン化を図ることができる。更に、
本発明の免疫学的反応性を有するエピトープには、T細
胞とも特異的に反応するエピトープが存在する。このエ
ピトープを指標として、牛肉及び牛乳並びにこれらを含
む加工食品のT細胞への反応性の制御を図ることができ
る。また、本発明の免疫学的反応性を有するエピトープ
の決定方法によれば、簡便且つ迅速に家畜血清アルブミ
ン中の免疫学的反応性を有するエピトープを決定するこ
とができる。
INDUSTRIAL APPLICABILITY As described above, since the immunologically reactive epitope of the present invention specifically reacts with the IgE antibody (that is, B cell) of a beef allergy patient, an antibody for detecting an allergen of BSA is prepared. Can be used as an antigen for. In addition, using the immunologically reactive epitope of the present invention as an index, it is possible to reduce the allergens of beef and milk and processed foods containing them. Furthermore,
Among the immunologically reactive epitopes of the present invention, there are epitopes that specifically react with T cells. By using this epitope as an index, it is possible to control the reactivity of beef and milk and processed foods containing them to T cells. Further, according to the method for determining an immunologically reactive epitope of the present invention, an immunologically reactive epitope in livestock serum albumin can be simply and quickly determined.

【0019】[0019]

【配列表】 <110> Nippon Meat Packers, Inc. <120> Immuno-reactive epitope of livestock serum albumin <160> 9 <210> 1 <211> 14 <212> PRT <213> Artificial Sequence <400> 1 Ser-Pro-Asp-Leu-Pro-Lys-Leu-Lys-Pro-Asp-Pro-Asn-Thr-Leu- 1 5 10 <210> 2 <211> 10 <212> PRT <213> Artificial Sequence <400> 2 Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- 1 5 10 <210> 3 <211> 6 <212> PRT <213> Artificial Sequence <400> 3 Glu-Tyr-Ala-Val-Ser-Val- 1 5 <210> 4 <211> 15 <212> PRT <213> Artificial Sequence <400> 4 Ala-Cys-Tyr-Thr-Ser-Val-Phe-Asp-Lys-Leu-Lys-His-Leu-Val-Asp- 1 5 10 15 <210> 5 <211> 5 <212> PRT <213> Artificial Sequence <400> 5 Leu-Ile-Leu-Asn-Arg- 1 5 <210> 6 <211> 3 <212> PRT <213> Artificial Sequence <400> 6 Glu-Ser-Lys- 1 <210> 7 <211> 6 <212> PRT <213> Artificial Sequence <400> 7 Ala-Phe-Asp-Glu-Lys-Leu- 1 5 <210> 8 <211> 5 <212> PRT <213> Artificial Sequence <400> 8 Pro-Asp-Thr-Glu-Lys- 1 5 <210> 9 <211> 4 <212> PRT <213> Artificial Sequence <400> 9 Glu-Asn-Phe-Val- 1[Sequence list] <110> Nippon Meat Packers, Inc. <120> Immuno-reactive epitope of livestock serum albumin <160> 9 <210> 1 <211> 14 <212> PRT <213> Artificial Sequence <400> 1 Ser-Pro-Asp-Leu-Pro-Lys-Leu-Lys-Pro-Asp-Pro-Asn-Thr-Leu-   1 5 10 <210> 2 <211> 10 <212> PRT <213> Artificial Sequence <400> 2 Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln-   1 5 10 <210> 3 <211> 6 <212> PRT <213> Artificial Sequence <400> 3 Glu-Tyr-Ala-Val-Ser-Val-   1 5 <210> 4 <211> 15 <212> PRT <213> Artificial Sequence <400> 4 Ala-Cys-Tyr-Thr-Ser-Val-Phe-Asp-Lys-Leu-Lys-His-Leu-Val-Asp-   1 5 10 15 <210> 5 <211> 5 <212> PRT <213> Artificial Sequence <400> 5 Leu-Ile-Leu-Asn-Arg-   1 5 <210> 6 <211> 3 <212> PRT <213> Artificial Sequence <400> 6 Glu-Ser-Lys-   1 <210> 7 <211> 6 <212> PRT <213> Artificial Sequence <400> 7 Ala-Phe-Asp-Glu-Lys-Leu-   1 5 <210> 8 <211> 5 <212> PRT <213> Artificial Sequence <400> 8 Pro-Asp-Thr-Glu-Lys-   1 5 <210> 9 <211> 4 <212> PRT <213> Artificial Sequence <400> 9 Glu-Asn-Phe-Val-   1

【図面の簡単な説明】[Brief description of drawings]

【図1】合成ペプチドに対するIgEの結合性を示す図
である。合成ペプチド(No.1〜16)はイムノプレートに
固定され、希釈したプール血清を用いたELISAに供し
た。なお、ndは非検出を意味する。
FIG. 1 shows the binding properties of IgE to synthetic peptides. The synthetic peptides (No. 1 to 16) were fixed on an immunoplate and subjected to ELISA using diluted pooled serum. Note that nd means non-detection.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 高畑 能久 茨城県つくば市緑ヶ原3丁目3番地 日本 ハム株式会社中央研究所内 (72)発明者 森松 文毅 茨城県つくば市緑ヶ原3丁目3番地 日本 ハム株式会社中央研究所内 Fターム(参考) 4H045 AA11 BA13 BA14 BA15 BA16 BA17 CA42 DA70 DA86 EA01 EA50 FA10    ─────────────────────────────────────────────────── ─── Continued front page    (72) Inventor Norihisa Takahata             3-3 Midorigahara, Tsukuba, Ibaraki Japan             Central Research Laboratory, Ham Co., Ltd. (72) Inventor Fumitake Morimatsu             3-3 Midorigahara, Tsukuba, Ibaraki Japan             Central Research Laboratory, Ham Co., Ltd. F-term (reference) 4H045 AA11 BA13 BA14 BA15 BA16                       BA17 CA42 DA70 DA86 EA01                       EA50 FA10

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 下記のアミノ酸配列又はそのN末端
及び/又はC末端に1〜5個のアミノ酸が付加したアミ
ノ酸配列を有するウシ血清アルブミンの免疫学的反応性
を有するエピトープ。 Ser-Pro-Asp-Leu-Pro-Lys-Leu-Lys-Pro-Asp-Pro-Asn-Th
r-Leu- Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Ala-Cys-Tyr-Thr-Ser-Val-Phe-Asp-Lys-Leu-Lys-His-Le
u-Val-Asp- Leu-Ile-Leu-Asn-Arg- Glu-Ser-Lys- Ala-Phe-Asp-Glu-Lys-Leu- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe-Val-
1. An immunologically-reactive epitope of bovine serum albumin having the following amino acid sequence or an amino acid sequence in which 1 to 5 amino acids are added to its N-terminal and / or C-terminal. Ser-Pro-Asp-Leu-Pro-Lys-Leu-Lys-Pro-Asp-Pro-Asn-Th
r-Leu- Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Ala-Cys-Tyr-Thr-Ser-Val-Phe- Asp-Lys-Leu-Lys-His-Le
u-Val-Asp- Leu-Ile-Leu-Asn-Arg- Glu-Ser-Lys- Ala-Phe-Asp-Glu-Lys-Leu- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe- Val-
【請求項2】 下記のアミノ酸配列又はそのN末端
及び/又はC末端に1〜5個のアミノ酸が付加したアミ
ノ酸配列を有するヒツジ血清アルブミンの免疫学的反応
性を有するエピトープ。 Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Leu-Ile-Leu-Asn-Arg- Pro-Asp-Thr-Glu-Lys- Glu-Asn-Phe-Val-
2. An immunologically-reactive epitope of sheep serum albumin having the following amino acid sequence or an amino acid sequence in which 1 to 5 amino acids are added to its N-terminal and / or C-terminal. Tyr-Ala-Asn-Lys-Tyr-Asn-Gly-Val-Phe-Gln- Glu-Tyr-Ala-Val-Ser-Val- Leu-Ile-Leu-Asn-Arg- Pro-Asp-Thr-Glu- Lys- Glu-Asn-Phe-Val-
【請求項3】 家畜の血清アルブミンのアミノ酸配
列と、ヒト又はペット動物の血清アルブミンのアミノ酸
配列を対比し、アミノ酸配列の異なる個所のアミノ酸配
列のペプチドを免疫学的検査に付して免疫学的反応性を
試験し、免疫学的反応性を有するペプチドを免疫学的反
応性を有するエピトープと決定する家畜血清アルブミン
の免疫学的反応性を有するエピトープの決定方法。
3. A method for comparing the amino acid sequence of domestic animal serum albumin with the amino acid sequence of human or pet animal serum albumin, and subjecting the peptides of the amino acid sequences having different amino acid sequences to immunological tests. A method for determining an immunologically-reactive epitope of livestock serum albumin, which tests reactivity and determines an immunologically-reactive peptide as an immunologically-reactive epitope.
JP2002057150A 2002-03-04 2002-03-04 Epitope having immunologic reactivity for farm animal serum albumin Pending JP2003252899A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002057150A JP2003252899A (en) 2002-03-04 2002-03-04 Epitope having immunologic reactivity for farm animal serum albumin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002057150A JP2003252899A (en) 2002-03-04 2002-03-04 Epitope having immunologic reactivity for farm animal serum albumin

Publications (1)

Publication Number Publication Date
JP2003252899A true JP2003252899A (en) 2003-09-10

Family

ID=28667485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002057150A Pending JP2003252899A (en) 2002-03-04 2002-03-04 Epitope having immunologic reactivity for farm animal serum albumin

Country Status (1)

Country Link
JP (1) JP2003252899A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008143494A1 (en) * 2007-05-22 2008-11-27 Erasmus University Medical Center Rotterdam Assay for detection of prostate cancer by means of proteolytic hsa markers
CN112272773A (en) * 2018-05-22 2021-01-26 过敏原有限责任公司 Peptides and methods for detecting peanut allergy
CN112480247A (en) * 2020-11-10 2021-03-12 中美福源生物技术(北京)股份有限公司 Anti-human serum albumin monoclonal antibody
CN113257355A (en) * 2021-05-17 2021-08-13 北京工商大学 Method for determining cross-allergen-acting surface sites related to eggs

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008143494A1 (en) * 2007-05-22 2008-11-27 Erasmus University Medical Center Rotterdam Assay for detection of prostate cancer by means of proteolytic hsa markers
CN112272773A (en) * 2018-05-22 2021-01-26 过敏原有限责任公司 Peptides and methods for detecting peanut allergy
CN112480247A (en) * 2020-11-10 2021-03-12 中美福源生物技术(北京)股份有限公司 Anti-human serum albumin monoclonal antibody
CN112480247B (en) * 2020-11-10 2023-09-22 华通福源生物技术(北京)股份有限公司 Anti-human serum albumin monoclonal antibodies
CN113257355A (en) * 2021-05-17 2021-08-13 北京工商大学 Method for determining cross-allergen-acting surface sites related to eggs
CN113257355B (en) * 2021-05-17 2023-08-11 北京工商大学 Method for determining cross allergen acting epitope related to eggs

Similar Documents

Publication Publication Date Title
Takahashi et al. Laminin γ‐1 and collagen α‐1 (VI) chain are galactose‐α‐1, 3‐galactose–bound allergens in beef
EP3364193B1 (en) Improved assay for the diagnosis of peanut allergy
TWI690537B (en) Novel macadamia allergen
US20240108719A1 (en) Allergy antigen and epitope thereof
US20230295251A1 (en) Allergy antigen and epitope for same
US20160116489A1 (en) Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults
Lorenz et al. Recombinant food allergens
AU2009234930B2 (en) Method of discriminating bovine, thus discriminated bovine and kit for discriminating bovine
CN112114150A (en) Method and product for diagnosing seafood allergy
WO2010101255A1 (en) Diagnostic reagent for crohn&#39;s disease
JP4734619B2 (en) New stress biomarkers and their uses
CN112079909A (en) Antigens and epitopes of allergy
JP2003252899A (en) Epitope having immunologic reactivity for farm animal serum albumin
CN106153935A (en) A kind of enzyme linked immunological kit of detection by quantitative CD79 α
Capsel et al. Composition and potency characterization of Mycobacterium avium subsp. paratuberculosis purified protein derivatives
JP5229789B2 (en) New stress biomarkers and their uses
Yang et al. Identification of immunoglobulin E epitopes on major allergens from dairy products after digestion and transportation in vitro
CN103376324A (en) Application of albumin as obesity-diabetes marker
JP5358808B2 (en) Tumor marker, tumor diagnostic kit, method for measuring tumor marker and tumor diagnostic method
Liu et al. Immunochromatrography detection of human lactoferrin protein in milk from transgenic cattle
US20210231678A1 (en) Allergy antigen and epitope thereof
EP3467499A1 (en) Egg allergy antigen
JP5322240B2 (en) Determination method for allergic disease and determination kit for allergic disease
JP2022157411A (en) New antigen of milk allergy
JP2012511325A (en) Recombinant antigen for detecting toxocariasis

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050228

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050609

A131 Notification of reasons for refusal

Effective date: 20080201

Free format text: JAPANESE INTERMEDIATE CODE: A131

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080606